It is a broadly described annual report of Biocon Limited in the year of 2017-2018. During the financial year, Total assets of the Company stood at Rs. 99,897 million. The Company’s revenues registered a growth of 6% to Rs. 43,359 million from Rs. 40,787 million in FY17. Other income for FY18 amounted to Rs. 1,247 million as against Rs. 988 million in FY17, primarily comprised income on investments at Rs. 628 million, foreign exchange gain Rs. 174 million and dividend income from subsidiaries at Rs. 145 million. Total expenses of the Company for the year Rs. 37,472 million. The Profit before tax and exceptional items for the year was Rs. 6,100 million as compared to Rs. 8,497 million in 2017. Profit after Tax (PAT) for the year stood at Rs. 4,531 million compared to Rs. 6,881 million for FY17. Profits for FY17 included a tax on an exceptional item of Rs. 78 million. The Earnings per share (EPS) of the Company for the year stood at Rs. 6.31.
The Board of Directors of the Company has recommended a Final Dividend of Rs. 1/- (@20%) per equity share for the financial year ended 31st March 2018, entailing a payout of Rs. 600 million.
More Annual Report of Biocon Limited:
